We are live on ! Find out more
IIM

Ironwood Investment Management Portfolio holdings

AUM $240M
1-Year Est. Return 45.82%
This Fund
S&P 500
This Quarter Est. Return
+6.01%
1 Year Est. Return
+45.82%
3 Year Est. Return
+149.14%
5 Year Est. Return
+180.33%
10 Year Est. Return
+990.3%
AUM
$202M
AUM Growth
+$9.23M
Cap. Flow
+$5.17M
Cap. Flow %
2.56%
Top 10 Hldgs %
22.38%
Holding
184
New
12
Increased
82
Reduced
47
Closed
4

Top Buys

Rank Stock Value
1
BBIO icon
BridgeBio Pharma
BBIO
+$1.89M
2
EVBG
Everbridge, Inc. Common Stock
EVBG
+$927K
3
ZETA icon
Zeta Global
ZETA
+$605K
4
IWM icon
iShares Russell 2000 ETF
IWM
+$598K
5
ENOV icon
Enovis
ENOV
+$574K

Top Sells

Rank Stock Value
1
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$856K
2
CL icon
Colgate-Palmolive
CL
+$770K
3
RVI
Retail Value Inc. Common Shares
RVI
+$511K
4
XOM icon
ExxonMobil
XOM
+$363K
5
GT icon
Goodyear
GT
+$301K

Sector Composition

Rank Sector Weight
1 Technology 31.87%
2 Industrials 12.5%
3 Consumer Discretionary 11.63%
4 Healthcare 11.63%
5 Financials 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CL icon
176
Colgate-Palmolive
CL
$73.6B
– –
-10,194
Closed -$770K
GT icon
177
Goodyear
GT
$1.74B
– –
-17,007
Closed -$301K
RDHL
178
Redhill Biopharma
RDHL
$3.59M
– –
-39
Closed -$177K
4 5 6 7
8

Similar funds

HIP
Hengistbury Investment Partners London, United Kingdom $240M AUM 17.74% 1-Year Est. Return
RTL
Red Tortoise LLC Atlanta, Georgia $240M AUM 19.84% 1-Year Est. Return
CIA
Caerus Investment Advisors West Lake Hills, Texas $240M AUM 27.37% 1-Year Est. Return
FWP
Forefront Wealth Partners Austin, Texas $239M AUM 16.12% 1-Year Est. Return
WWA
Wealth Watch Advisors Englewood, Colorado $239M AUM 21.17% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
DCC
Dow Chemical Company Midland, Michigan $239M AUM 13.16% 1-Year Est. Return
LOM
LTS One Management New York $239M AUM 18.42% 1-Year Est. Return

Ironwood Investment Management's Q4 2021 Portfolio in Review

As of Q4 2021, Ironwood Investment Management held 184 positions worth $202M, up 4.8% from $193M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Ironwood Investment Management's Q4 2021 filing shows 12 new, 82 increased, 47 reduced and 4 closed positions. Its largest new stake was Zeta Global: 72,054 shares worth $607K. The largest sale was Aurinia Pharmaceuticals, an estimated $856K.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Ironwood Investment Management's largest Q4 2021 buy was Zeta Global: 72,054 shares worth $607K.
  • Ironwood Investment Management added most to BridgeBio Pharma in Q4 2021, an estimated $1.89M increase.
  • Ironwood Investment Management's biggest Q4 2021 reduction was Aurinia Pharmaceuticals, cutting an estimated $856K.
  • Ironwood Investment Management fully exited Colgate-Palmolive in Q4 2021, selling an estimated $770K.
  • Ironwood Investment Management's ten largest holdings make up 22% of its $202M portfolio in Q4 2021.
  • Ironwood Investment Management opened 12 new positions and closed 4 in Q4 2021.
  • Ironwood Investment Management's portfolio value rose 4.8% quarter-over-quarter to $202M.

Based on Ironwood Investment Management's 13F filing for Q4 2021, filed 10 Feb 2022.